UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private

Issuer Pursuant to Rule

13a-16 or 15d-16 ~~under~~of the

Securities Exchange Act

of 1934

For the month of ~~March~~ April 2026

Commission File

Number: 001-38283

InflaRx N.V.

Winzerlaer Str. 2

07745 Jena,

Germany

(+49) 3641508180

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

~~EXPLANATORY~~INCORPORATION ~~NOTE~~BY REFERENCE

AsOn ~~previously~~April ~~announced~~2, ~~on March 19,~~ 2026, InflaRx N.V. (convened the ~~“Company”) issued~~annual ageneral ~~press~~meeting ~~release~~of ~~titled,~~shareholders ~~“InflaRx~~to ~~Reports~~be ~~Full~~held ~~Year~~on ~~2025~~April 23, ~~Results~~2026 and ~~Highlights~~made ~~Key~~available ~~Achievements~~to its shareholders certain other materials in connection with such meeting. Such materials are attached as exhibits to this Form 6-K and ~~Expected~~are ~~Milestones~~incorporated by reference herein.”

A copy of the press release is attached as Exhibit 99.1 to this report on Form 6-K. Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

EXHIBIT INDEX

Exhibit No.	Description
Exhibit		Description of Exhibit
99.1	~~Press Release, dated March 19, 2026~~	Convening Notice, including Agenda and Explanatory Notes
99.2		Voting Proxy

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	~~INFLARX N.V.~~		INFLARX N.V.
Date: March 19, 2026	By:	/s/ Niels Riedemann
Date: April 2, 2026
	Name:	Niels Riedemann
			By:	/s/ Niels Riedemann
	Title:	Chief Executive Officer
				Name:	Niels Riedemann
				Title:	Chief Executive Officer

Filing Compare · InflaRx N.V.